Next Century Growth Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xometry
XMTR
|
+$25.3M |
| 2 |
Lantheus
LNTH
|
+$14.4M |
| 3 |
Arteris
AIP
|
+$13.1M |
| 4 |
CS Disco
LAW
|
+$10.3M |
| 5 |
Treace Medical Concepts
TMCI
|
+$9.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SiTime
SITM
|
+$34.6M |
| 2 |
OptimizeRx
OPRX
|
+$23M |
| 3 |
HealthEquity
HQY
|
+$11.8M |
| 4 |
ACCD
Accolade Inc
ACCD
|
+$9.76M |
| 5 |
SI
Silvergate Capital Corporation
SI
|
+$8.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.18% |
| 2 | Technology | 28.71% |
| 3 | Industrials | 18.2% |
| 4 | Financials | 12.38% |
| 5 | Consumer Discretionary | 7.34% |
Similar funds
Next Century Growth Investors's Q4 2021 Portfolio in Review
As of Q4 2021, Next Century Growth Investors held 137 positions worth $1.11B, down 3.7% from $1.15B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Next Century Growth Investors withdrew a net $65M in Q4 2021, closing 16 positions and reducing 77 holdings. Its most notable exit was OptimizeRx, an estimated $23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Next Century Growth Investors opened a new position in Arteris worth $12.2M.
- Next Century Growth Investors's largest Q4 2021 buy was Arteris: 577,204 shares worth $12.2M.
- Next Century Growth Investors added most to Xometry in Q4 2021, an estimated $25.3M increase.
- Next Century Growth Investors's biggest Q4 2021 reduction was SiTime, cutting an estimated $34.6M.
- Next Century Growth Investors fully exited OptimizeRx in Q4 2021, selling an estimated $23M.
- Next Century Growth Investors's ten largest holdings make up 27% of its $1.11B portfolio in Q4 2021.
- Next Century Growth Investors opened 8 new positions and closed 16 in Q4 2021.
- Next Century Growth Investors's portfolio value fell 3.7% quarter-over-quarter to $1.11B.
Based on Next Century Growth Investors's 13F filing for Q4 2021, filed 14 Feb 2022.